Search Results for "intake"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for intake. Results 11 to 20 of 100 total matches.

Treatment of Heat Injury

   
The Medical Letter on Drugs and Therapeutics • Jul 13, 1990  (Issue 822)
to maintain adequate fluid intake. The dosage of any drug that affects fluid balance or temperature ...
Summer heat waves cause thousands of cases of heat-related illness in the USA each year and hundreds of heat-related deaths, especially among the elderly. A few principles may be helpful in preventing and treating heat injury.
Med Lett Drugs Ther. 1990 Jul 13;32(822):66-8 |  Show IntroductionHide Introduction

Neotame - a new artificial sweetener

   
The Medical Letter on Drugs and Therapeutics • Aug 19, 2002  (Issue 1137)
weight gain that appeared to be unrelated to food intake. A 104-week study in rats found no evidence ...
Neotame (Neotame - NutraSweet Co.), an analog of aspartame (NutraSweet, and others), has been approved by the FDA for use as a nonnutritive sweetener and "flavor enhancer" in foods and beverages. Other non-caloric sweeteners available in the US include saccharin (Sweet'N Low, and others), acesulfame potassium (Sunette - Medical Letter, 1988; 30:116) and sucralose (Splenda - Medical Letter, 1998; 40:67). Neotame was approved for use in Australia and New Zealand in 2001.
Med Lett Drugs Ther. 2002 Aug 19;44(1137):73-4 |  Show IntroductionHide Introduction

Mercury in Fish

   
The Medical Letter on Drugs and Therapeutics • Dec 14, 2009  (Issue 1327)
have recommended limiting the intake of seafood with a substantial mercury content during pregnancy. Since ...
Recent news articles about mercury in fish may lead some patients to seek more information from their healthcare providers. For most Americans, seafood is the major source of exposure to mercury. The mercury in seafood is in the form of methylmercury, a potential neurotoxin formed by the organification of elemental mercury by marine microorganisms like plankton, which are then consumed by aquatic animals and concentrated up the food chain.
Med Lett Drugs Ther. 2009 Dec 14;51(1327):103-4 |  Show IntroductionHide Introduction

Folic Acid Supplementation to Prevent Neural Tube Defects

   
The Medical Letter on Drugs and Therapeutics • Mar 01, 2004  (Issue 1177)
has increased folic acid intake by about 215 to 240 µg/d (EP Quinlivan and JF Gregory III, Am J Clin Nutr 2003 ...
Many women of child-bearing age now take folic acid supplements of 400 ╡g per day to prevent neural tube defects in their offspring (Medical Letter 1998; 40:75). An FDA advisory committee has recommended development of a combination tablet containing an oral contraceptive and 400 ╡g of folic acid. A recent editorial in the New England Journal of Medicine suggested that folic acid doses should be higher (NJ Wald, N Engl J Med 2004; 350:101).
Med Lett Drugs Ther. 2004 Mar 1;46(1177):17-8 |  Show IntroductionHide Introduction

Comparison Table: Inhaled Drugs for Treatment of COPD (online only)

   
The Medical Letter on Drugs and Therapeutics • Sep 02, 2024  (Issue 1710)
of breath intake to deliver drug to the lungs ▶ Assembly of Respimat inhaler may be difficult for some ...
View the Comparison Table: Inhaled Drugs for Treatment of COPD
Med Lett Drugs Ther. 2024 Sep 2;66(1710):e143-7   doi:10.58347/tml.2024.1710b |  Show IntroductionHide Introduction

Chromium Supplementation

   
The Medical Letter on Drugs and Therapeutics • Jan 16, 2006  (Issue 1226)
and mineral preparations. REQUIREMENTS — For adults, 20-35 mcg/day is thought to be an adequate intake (45 ...
Chromium is marketed as a dietary supplement, usually containing 20-500 mcg of a chromium salt. It has been promoted for weight loss, muscle building, and for prevention and treatment of diabetes, among other claims. As a dietary supplement, chromium can be sold without proof of efficacy or safety.
Med Lett Drugs Ther. 2006 Jan 16;48(1226):7-8 |  Show IntroductionHide Introduction

Prevention and Treatment of Heat Injury

   
The Medical Letter on Drugs and Therapeutics • Jul 21, 2003  (Issue 1161)
adequate fluid intake. People engaged in strenuous exercise in hot weather should drink water more ...
Summer heat waves cause thousands of cases of heat-related illness in the US each year and hundreds of heat-related deaths, especially among the elderly. This review describes the contributing factors, clinical signs, and ways to prevent and treat heat injury.
Med Lett Drugs Ther. 2003 Jul 21;45(1161):58-60 |  Show IntroductionHide Introduction

In Brief: Calcium and Vitamin D to Prevent Osteoporotic Fractures

   
The Medical Letter on Drugs and Therapeutics • Jun 25, 2012  (Issue 1393)
that there is no evidence that patients with an adequate intake of calcium (1000-1200 mg/day) and vitamin D (600-800 IU ...
The US Preventive Services Task Force (USPSTF) has issued a Draft Recommendation Statement saying, in effect, that community-dwelling women and men should not take calcium and vitamin D supplements for primary prevention of osteoporotic fractures because the evidence that they are helpful is insufficient and they increase the risk of kidney stones. The Medical Letter has said previously that there is no evidence that patients with an adequate intake of calcium (1000-1200 mg/day) and vitamin D (600-800 IU/day) will benefit from taking supplements.11. Drugs for postmenopausal osteoporosis. Treat...
Med Lett Drugs Ther. 2012 Jun 25;54(1393):52 |  Show IntroductionHide Introduction

Vitamins for Cataract Prevention

   
The Medical Letter on Drugs and Therapeutics • Jun 16, 2008  (Issue 1288)
-oxidant effects in vivo. A high intake of vitamin A has been associated with an increased risk of hip ...
Cataracts are the leading cause of blindness worldwide because cataract surgery is not available to most people in developing countries.
Med Lett Drugs Ther. 2008 Jun 16;50(1288):46-7 |  Show IntroductionHide Introduction

Duaklir Pressair: Another LAMA/LABA Inhaler for COPD

   
The Medical Letter on Drugs and Therapeutics • Sep 23, 2019  (Issue 1581)
Not dependent on strength of breath intake Requires coordination of inhalation with hand-actuation ...
The FDA has approved Duaklir Pressair (Circassia), a fixed-dose combination of the long-acting muscarinic antagonist (LAMA) aclidinium bromide and the longacting beta2-adrenergic agonist (LABA) formoterol fumarate, for maintenance treatment of chronic obstructive pulmonary disease (COPD). Aclidinium/formoterol is the fifth LAMA/LABA combination to be approved in the US for this indication.
Med Lett Drugs Ther. 2019 Sep 23;61(1581):149-51 |  Show IntroductionHide Introduction